共查询到20条相似文献,搜索用时 31 毫秒
1.
Charis Eng Lois M. Mulligan Darrin P. Smith Catherine S. Healey Andrea Frilling Friedhelm Raue Hartmut P. H. Neumann Roswitha Pfragner Annemarie Behmel Maria J. Lorenzo Timothy J. Stonehouse Margaret A. Ponder Bruce A. J. Ponder 《Genes, chromosomes & cancer》1995,12(3):209-212
Medullary thyroid carcinoma (MTC) occurs sporadically or as part of the inherited cancer syndrome multiple endocrine neoplasia (MEN) type 2. In MEN 2A, germline missense mutations are found in one of five cysteine codons within exons 10 and 11 in the extracellular domain of the RET protooncogene. In MEN 2B, germline mutations occur in codon 918 (exon 16) within the catalytic core of the tyrosine kinase domain. To determine if RET mutations similar to those in MEN 2A and 2B play a role in the pathogenesis of sporadic MTC, we analysed 71 sporadic tumours comprising 68 primary tumours and three cell lines, for mutations in RET exons 10, 11, and 16. We found that 23% of sporadic MTC had RET codon 918 mutations, while only 3% had exon 10 mutations, and none had mutations in exon 11. We found no exon 16 mutations in MTC from 14 MEN 2A cases. Thus, exon 10 and 11 mutations, commonly found in familial MTC and MEN 2A, rarely occur in sporadic MTC; somatic mutation of RET codon 918 appears to play a role in the tumourigenesis of a significant minority of sporadic MTC but not MEN 2A tumours. In addition to their biological interest, these findings may have some clinical application in determining whether a patient presenting with isolated MTC is truly sporadic or is part of an inherited cancer syndrome. 相似文献
2.
Syuya Shirahama K. Ogura Hiroshi Takami Kunihiko Ito Tohichi Tohsen Akira Miyauchi Yusuke Nakamura First 《Journal of human genetics》1998,43(2):101-106
Multiple endocrine neoplasia types 2A and 2B (MEN2A and MEN2B) and familial medullary thyroid carcinomas (FMTC) are caused
by germline mutations in the RET proto-oncogene. To investigate the spectrum of RET mutations among Japanese patients, we screened the RET gene in 71 patients with thyroid carcinomas. The panel included representatives of 44 families carrying FMTC or MEN2, 22
sporadic medullary thyroid carcinomas (MTCs), and five MTCs without familial information. Mutations in nucleotide sequences
encoding one of three specific cysteine residues in the extracellular domain of the RET protein were found in 33 of the 34 MEN2A patients and in five of the six FMTC patients examined. A mutation at codon 918,
causing the substitution of threonine for methionine in the tyrosine kinase domain of the protein, was found in germline DNAs
of all four patients with MEN2B and in two of the 22 patients with sporadic MTCs; codon 918 was mutated somatically in tumor
DNAs from three other sporadic cases. Germline mutations of codon 768, GAG to GAC (Glu to Asp), were detected in one FMTC,
in one patient with sporadic MTC, and in one of the patients without familial information. Two somatic mutations, an Asp to
Gly substitution at codon 631 and a Cys to Arg substitution at codon 634, had not been reported previously. Of five germline
mutations found among the 22 sporadic cases, four were confirmed as de novo mutations since in each case neither parent carried
the mutation. As nearly one-fourth of the patients with sporadic MTCs carried germline mutations and 50% of their children
are expected to develop MTC and other endocrine tumors, these results indicated the importance of careful clinical surveillance
of family members of any patient with MTC.
Received: August 22, 1997 / Accepted: October 22, 1997 相似文献
3.
Mutation of RET codon 768 is associated with the FMTC phenotype 总被引:3,自引:0,他引:3
Lara M. Boccia Jane S. Green Carol Joyce Charts Eng Sherryl A. M. Taylor Lois M. Mulligan 《Clinical genetics》1997,51(2):81-85
Multiple endocrine neoplasia type 2A (MEN 2A), type 2B (MEN 2B), and familial medullary thyroid carcinoma (FMTC) are inherited cancer syndromes resulting from mutations in the RET proto-oncogene. Missense mutations of five codons in exons 10 and 11 are found in both MEN 2A and FMTC families, while mutations at codon 768 in exon 13 have been identified in three FMTC families. We report here the results of mutation analysis on a large multi-generation family with multiple cases of medullary thyroid carcinoma (MTC) or C-cell hyperplasia and two individuals with isolated adrenal medullary hyperplasia. A mutation in exon 13, which alters codon 768 from a GAG (Glu) to a GAC (Asp), was found to segregate with the FMTC phenotype in this family but not with the adrenal medullary hyperplasia. These findings suggest that the codon 768 mutation does not predispose to adrenal medullary hyperplasia, but is an accurate predictor of the MTC phenotype in this family. 相似文献
4.
Komminoth P Muletta-Feurer S Saremaslani P Kunz EK Matias-Guiu X Hiort O Schroder S Seelentag WK Roth J Heitz PU 《Endocrine pathology》1995,6(4):267-278
In this article, we summarize our recent findings on rearranged during transfection (RET) mutations in a series of 46 sporadic as well as multiple endocrine neoplasia (MEN) type 2-associated tumors and present
results of our family screening efforts to identify MEN 2 and MEN 1 gene carriers.
A nonisotopic polymerase chain reaction-based single-strand conformation polymorphism (PCR-SSCP) analysis and heteroduplex
gel electrophoresis method was used to screen DNA extracted from archival specimens of 22 patients with MEN 2-associated and
24 patients with sporadic tumors for mutations inRET exons 10, 11, 13, and 16. Point mutations were identified by nonisotopic cycle sequencing of PCR products using an automated
DNA sequencer.
We found six different missense germline mutations at cysteine residues encoded by exons 10 and 11 in all patients with MEN
2A or familial medullary thyroid carcinoma (FMTC). The frequency of mutations at codon 634 was higher in patients with MEN
2A than with FMTC and a634 Cys→Arg mutation was associated with parathyroid disease. A germline Met→Thr point mutation at codon 918 of theRET tyrosine kinase domain encoded by exon 16 was identified in all MEN 2B patients. Nonpredicted inheritable medullary thyroid
carcinomas (MTCs) were detected in two patients and a mosaic postzygotic mutation was found in one additional patient.
Tumor-specific (somatic) Met→Thr point mutations at codon 918 were identified in 5 of 13 sporadic MTCs and 2 of 8 sporadic
pheochromocytomas (PCCs). The remaining sporadic tumors lacked mutations in all fourRET exons tested. In exon 13, a nucleic acid polymorphism (CTT/CTG; Leu) at codon 769 was identified, which is present in approx
40% of the examined population.
Our study demonstrates that the molecular methods used are not only suitable to identify asymptomatic individuals at risk
for MEN 2A, FMTC, and MEN 2B, but also to distinguish sporadic from inherited tumors using archival tissue specimens; and
that more tumors than clinically expected are inheritable, indicating the need for genetic analysis of all MTC and PCC patients. 相似文献
5.
RET proto-oncogene mutations in French MEN 2A and FMTC families 总被引:3,自引:0,他引:3
Schuffeneker Isabelle; Billaud Marc; Calender Alain; Chambe Beatrice; Ginet Nicole; Calmettes Claude; Modlglian Elisabeth; Lenolr Gilbert M.; GETC 《Human molecular genetics》1994,3(11):1939-1943
Constitutional mutations of the RET proto-oncogene have beenidentified in multiple endocrine neoplasia type 2A (MEN 2A),type 2B (MEN 2B) and familial medullary thyroid carcinoma (FMTC)families. We sequenced RET exons 10 and 11 in 86 unrelated patientswith an inherited predisposition to MTC (excluding MEN 2B).Germ-line mutations were Identified in 93% of the MEN 2A familiesand 67% of the FMTC families tested. All were missense mutationsaffecting one of three cysteines in the extracellular domainof the RET tyrosine kinase receptor. The prevalence of phaeochromocytomaand hyperparathyroidism was significantly higher in familieswith a mutation of cysteine 634. These data confirm the preferentiallocalisation of MEN 2A and FMTC associated mutations and thestrong correlation between clinical manifestations and the positionof RET mutation. Although direst sequencing of RET exons 10and 11 allows the identification of a constitutional mutationin a large proportion of MEN 2A and FMTC families, our datasustain the existence of other MTC predisposing mutations elsewherein RET coding or regulating region. 相似文献
6.
Medullary thyroid carcinoma (MTC) occurs as a sporadic tumor or in connection with the inherited cancer syndromes of multiple
endocrine neoplasia (MEN) types 2A and 2B and familial MTC. Missense RET proto-oncogene mutations of one of cysteine codons in exons 10 and 11 are found in the majority of families with MEN 2A and
or familial MTC. In MEN 2B, mutations at codon 918, exon 16, have been identified in most of the affected individuals. In
a significant amount of sporadic MTC somatic codon 918 mutations appear. In addition to these, a 6-bp deletion including codon
630 and a 24-bp deletion including codon 634 combined with a 6-bp insertion have been observed. We report on a 27-bp deletion
in exon 10 as a somatic mutation associated with a sporadic medullary thyroid carcinoma.
Received: 15 September 1997 / Accepted: 19 December 1997 相似文献
7.
In multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid cancer (FMTC), the majority of germline mutations are restricted to specific positions in exons 10 and 11 of the RET gene. However, germline mutations may very occasionally occur in other exons, including exon 14 of the RET gene. Interestingly, an increased frequency of a rare germline sequence variant of the RET exon 14, S836S, has been detected in patients with sporadic medullary thyroid cancer (MTC), and this variant has been proposed to play a role in the genesis of MTC and, perhaps, FMTC. In this study we report the segregation of a germline V804L mutation and a germline sequence variant S836S in exon 14 of the RET gene in an extended Hungarian FMTC kindred comprising 80 individuals of four generations. Molecular analysis of the RET gene was performed by direct DNA sequencing in 23 family members, of whom 12 had the V804L mutation, three had the V804L mutation and S836S polymorphism in separate alleles, and six had the S836S polymorphism, all in heterozygous forms. Two of the family members had neither mutation nor polymorphism of the RET gene. Three of the family members who had the V804L mutation and one member who could not be tested for mutation were operated for non-metastatic MTC, while one member with MTC who had the V804L mutation refused surgery. In all patients affected with MTC, the disease developed relatively late in life and never caused death. None of the other family members carrying the V804L mutation and/or the S836S polymorphism had clinical or biochemical evidence of MTC. These observations suggest that the co-existence of the V804L mutation and S836S polymorphism in separate alleles does not seem to aggravate the relatively low-risk disease phenotype characteristic in most patients with codon 804 mutations of the RET exon 14. 相似文献
8.
Three novel mutations in the RET proto-oncogene 总被引:2,自引:0,他引:2
V. Kalinin F. Amosenko M. Shabanov L. Lubchenko S. Hosch R. Garkavtseva J. Izbicki 《Journal of molecular medicine (Berlin, Germany)》2001,79(10):609-612
Medullary thyroid carcinoma (MTC) occurs as a sporadic tumor or in connection with inherited cancer syndromes of multiple endocrine neoplasia type 2 and familial MTC. Missense RET proto-oncogene mutations and small in-frame deletions are found in most of the cases. In a significant amount of sporadic MTC cases somatic mutation at codon 918 (exon 16), or at codons 609, 611, 618, 620 (exon 10), or codons 630, 634 (exon 11) appear. We report here on three new somatic cell missense mutations of the RET proto-oncogene associated with sporadic MTC. In one tumor mutation at codon 922 TCC(Ser)-->TTC(Phe) in exon 16 was found. In another tumor two mutations at codons 639 GCA(Ala)-->GGA(Gly) and 641 GCT(Ala)-->CGT(Arg) in the exon 11 were observed. Allele-specific PCR followed by sequencing demonstrated the presence of both mutations at the same allele. 相似文献
9.
Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. 下载免费PDF全文
B. C. Padberg S. Schrder W. Jochum H. Kastendieck J. Roth P. U. Heitz P. Komminoth 《The American journal of pathology》1995,147(6):1600-1607
We investigated the possible role of RET proto-oncogene mutations in the development of sporadic hyperplastic, benign, and malignant parathyroid lesions. DNA extracted from paraffin-embedded specimens of forty parathyroid lesions was screened for RET proto-oncogene point mutations in exons 10, 11, and 16 by nonisotopic polymerase chain reaction-based single-strand conformation polymorphism and heteroduplex gel electrophoresis. The nucleotide sequence of samples with aberrant band patterns was identified by nonisotopic direct sequencing of polymerase chain reaction-amplified DNA. Parathyroids of seven patients with multiple endocrine neoplasia type 2A (MEN 2A) and MEN 2B served as positive controls. None of the eight hyperplastic lesions, three cases of parathyromatosis, ten parathyroid adenomas, eleven carcinomas or one normal parathyroid gland contained mutations in each of the three RET exons tested. Six MEN-2A-associated hyperplastic glands exhibited identical band shifts in the polymerase chain reaction single-strand conformation polymorphism analysis of exon 11, which corresponded to a Cys 634-->Arg substitution in the nucleotide sequence analysis (TGC-->CGC), whereas in the MEN 2B parathyroid specimen a point mutation was found at codon 918 of exon 16 (ATG-->ACG), causing a Met 918-->Thr substitution. Our data indicate that RET mutations of the MEN 2 loci in exons 10, 11, and 16 are not involved in the development of sporadically occurring benign or malignant parathyroid lesions. Furthermore, our results are in accordance with the observation that MEN 2A patients with Cys 634-->Arg (germline) mutations have a higher risk of developing parathyroid disease than those with other mutations at codon 634. 相似文献
10.
2型多发性内分泌腺瘤(multiple endocrine neoplasia type 2,MEN 2)是一种以甲状腺、肾上腺髓质和甲状旁腺内神经内分泌细胞发生增生或肿瘤为主要特征的肿瘤,一般呈常染色体显性遗传方式。MEN 2可分为3种亚型:2A型(MEN2A)、家族性甲状腺髓样癌型(FMTC)和2B型(MEN2B)。原癌基因RET是迄今发现的唯一与MEN2发病相关的基因,突变热点主要为第10、11、13~16外显子。98%的MEN2A患者,98%以上的MEN 2B患者,以及约95%的FMTC家系,均可检测到RET基因的致病突变。另外,约5%的MEN2A和50%的MEN2B先证者可能源自RET基因的种系自发突变。MEN2患者的子代遗传到RET突变基因的风险高达50%,故对先证者、家系和亲属进行RET基因突变的筛查,不仅可以早期预防和诊治本病,而且可以实施后续的产前诊断、植入前遗传学诊断,具有重要的医学遗传学和优生学意义。本文对MEN2的相关分子遗传学研究进展作一简单综述。 相似文献
11.
Josep Oriola Concepcin Pramo Irene Halperin Ricardo V. García-Mayor Fca Rivera-Fillat 《American journal of medical genetics. Part A》1998,78(3):271-273
Medullary thyroid carcinoma (MTC) may occur sporadically or as part of the autosomal dominant multiple endocrine neoplasia type 2 (MEN 2). Three hereditary forms of MEN 2 have been identified: MEN 2A, MEN 2B, and familial MTC (FMTC). Missense germ-line mutations in the RET proto-oncogene have been identified as cause of these endocrine diseases. Mutations are found in exons 10 and 11 in MEN 2A and FMTC families and in a small number of families in exons 13, 14, and 15. Although a strong correlation between codon mutations and phenotypes has been described, not all the expected cystein codon mutations have been found. Therefore, the more mutations are found, the better it is possible to establish phenotype-genotype correlations. We report on a novel RET mutation at codon 611 in a family with MTC without other clinical manifestations and of rather benign course. Am. J. Med. Genet. 78:271–273, 1998. © 1998 Wiley-Liss, Inc. 相似文献
12.
Multiple Endocrine Neoplasia (MEN) 2A is an inherited disease characterized by the development of medullary thyroid carcinoma (MTC), pheochromocytoma(PHCH) and hyperparathyroidism(HPT). It has recently been shown to be associated with germline mutations in the RET proto-oncogene. Genetic testing for RET mutations will, therefore allow the identification of people with asymptomatic MEN 2 who can be offered prophylactic thyroidectomy and biochemical screening as preventive measures. No genetic study based on RET mutation detection has been available in India so far. The aim of the present study is to detect the proportion of MTC cases having inherited germline or somatic RET mutations and to identify family members at risk for MEN and, thereby the feasibility of screening for MEN. DNA extracted from the peripheral blood and somatic (tumor) tissues were subjected to PCR using primers for exons 10,11 and 16. A few samples were subjected to direct sequencing. Germline mutations were identified in 3 of 4 MEN 2A patients, 18 of 24 sporadic MTC(SMTC), 2 of 4 children of MEN2A and 8 relatives of SMTC. Common mutation was in exon 10 and 11 (c634). It is recommended that RET mutation analysis and counseling of patients and their immediate relatives be introduced on a regular basis to identify gene carriers. 相似文献
13.
Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation 总被引:6,自引:0,他引:6
The RET proto-oncogene encodes a transmembrane receptor with tyrosine
kinase activity. Germline mutations in RET are responsible for a number of
inherited diseases. These include the dominantly inherited cancer syndromes
multiple endocrine neoplasia types 2A and 2B (MEN 2A and MEN 2B) and
familial medullary thyroid carcinoma (FMTC), as well as some cases of
familial Hirschsprung disease (HSCR1). RET mutations in HSCR1 have been
shown to cause a loss of RET function, while the cancer syndromes result in
RET oncogenic activation. Occasionally MEN 2A or FMTC occurs in association
with HSCR1, albeit with low penetrance. An initial report linked HSCR1 in
MEN 2A solely to the C618R and C620R RET mutations. In this study we have
analyzed 44 families with MEN 2A. HSCR1 co-segregated with MEN 2A in seven
(16%) of the 44 families. The predisposing RET mutation in all seven
families had been previously reported in MEN 2A or FMTC and occurred in
exon 10 at codons 609, 618 or 620, resulting in C609Y, C618S, C620R or
C620W substitution. MEN 2A families with RET exon 10 Cys mutations had a
substantially greater risk of developing HSCR1 than those with the more
common RET exon 11 Cys634 or exon 14 c804 mutations (P = 0.0005). These
findings suggest that expression of HSCR1 in MEN 2A may be peculiar to RET
exon 10 Cys mutations . However, HSCR1 in MEN 2A is not exclusive to C618R
or C620R RET mutations and can occur with other exon 10 Cys amino acid
substitutions. The strong correlation between disease phenotype and
position of the MEN 2A RET mutation suggests that oncogenic activation of
RET alone is insufficient to account for co-expression of the diseases.
相似文献
14.
Mulligan Lois M.; Eng Charts; Attle Tanla; Lyonnet Stanislas; Marsh Debbie J.; Hyland Valentine J.; Robinson Bruce G.; Frilling Andrea; Verellen-Dumoulln Christine; Safar Anne; Venter Deon J.; Munnich Arnold; Ponder Bruce A.J. 《Human molecular genetics》1994,3(12):2163-2168
Mutations of the RET proto-oncogene are the underlying causeof some cases of Hlrschsprung disease (HSCR) and the Inheritedcancer syndromes multiple endocrine neoplasia types 2A (MEN2A) and 2B (MEN 2B) and familial medullary thyroid carcinoma(FMTC). In HSCR these mutations are dispersed throughout thegene, while in MEN 2A and FMTC, they are tightly clustered Infive cystelne codons of the RET extracellular domain. HSCR andMEN 2 are usually distinct but occasional families have beenreported wtth both diseases. In each of five families with HSCRwith or without MEN 2A or FMTC, we have identified a nucleotidesubstitution In one of the five cystelne codons previously associatedwith MEN 2A or FMTC. In one family, which had HSCR as its onlyphenotype, we detected a Cys-Trp mutation at codon 609 whichhad not been previously observed. In three families, both HSCRand MEN 2A were associated with a single CysArg mutationat either codon 618 or 620 of RET. In the fifth family, FMTCand HSCR were present but we could not determine whether HSCRarose from mutation of the RET locus. We suggest that specificmutations In cysteine codons 618 and 620 result In MEN 2A orFMTC, but can also predispose to HSCR with low penetrance. 相似文献
15.
B. Sanchez M. Robledo J. Biarnes M. Saez V. Volpini J. Benitez E. Navarro A. Ruiz G. Antinolo S. Borrego 《Journal of medical genetics》1999,36(1):68-70
The RET proto-oncogene encodes a receptor tyrosine kinase expressed in neural crest derived tissues. Germline mutations in the RET proto-oncogene are responsible for three different dominantly inherited cancer syndromes: multiple endocrine neoplasia type 2A (MEN 2A), type 2B (MEN 2B), and familial medullary thyroid carcinoma (FMTC). MTC can also occur sporadically. Molecular characterisation of the RET proto-oncogene has been performed by PCR-SSCP analysis, direct DNA sequencing, and restriction enzyme analysis in 49 unrelated, Spanish, MEN 2 families: 30 MEN 2A families, six FMTC families, and 13 families classified as "other". Germline missense mutations in one of six cysteine codons (609, 611, 618, and 620 in exon 10, and codons 630 and 634 in exon 11), which encode part of the extracellular cysteine rich domain of RET, have been detected in the majority of these families: 100% of MEN 2A families, 67% of FMTC families, and 54% of families classified as "other". No RET mutations in exons 10, 11, 13, 14, 15, or 16 were detected in the remaining families. The most frequent RET mutation in MEN 2A Spanish families is C634Y, occurring in 73% of cases. Haplotype analysis does not exclude the possibility of founder effects in Spanish MEN 2A families with the C634Y mutation.
相似文献
相似文献
16.
González-Yebra B Medrano ME Mantilla A Palma V Colin C Hernández DM Tapia J Dawson B Salcedo M 《Endocrine pathology》2003,14(1):71-80
Multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid carcinoma (FMTC) are characterized by development of medullary thyroid carcinoma (MTC) and caused by germline RET mutations. Patients with MEN 2A also develop pheochromocytoma and/or hyperparathyroidism (HPT). However, MEN 2A-affected individuals could display the FMTC phenotype at first clinical manifestation. To establish the correct phenotype and improve clinical management of patients affected by hereditary MTC, clinical screening, RET mutational analysis, penetrance of MTC, and genotype-phenotype correlation were performed in a large, suspected FMTC kindred of 86 individuals. Germline C634Y RET mutation was confirmed in 22 individuals, 15 of whom were thyroidectomized when high serum calcitonin levels were detected. MTC was confirmed in 12 individuals and C-cell hyperplasia in 3. HPT was detected in two patients. High penetrance of MTC at young age (79% at 30 yr of age) was found. This family was considered to be affected by FMTC for several years because MTC was the sole clinical manifestation. However, our results allowed reclassifying the family as MEN 2A, thereby improving clinical management of family members. Our findings regarding penetrance and genotype-phenotype correlation suggest that patients considered to have FMTC may in fact have MEN 2A in some kindreds. 相似文献
17.
Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease 总被引:1,自引:0,他引:1
Nishikawa M Murakumo Y Imai T Kawai K Nagaya M Funahashi H Nakao A Takahashi M 《European journal of human genetics : EJHG》2003,11(5):364-368
Germline mutations in the RET proto-oncogene are responsible for the development of human hereditary diseases, including multiple endocrine neoplasia (MEN) type 2A and 2B, familial medullary thyroid carcinoma (FMTC), and Hirschsprung's disease (HSCR). It has been reported that some families developed both MEN 2A/FMTC and HSCR, in which a mutation in a cysteine residue at codon 609, 618, or 620 in the RET gene was present. Here we report a novel RET mutation detected in a Japanese family with medullary thyroid carcinoma and HSCR. A germline mutation in cysteine 611 of the RET gene was identified in this family, which introduced an amino-acid change from cysteine to serine. By biological and biochemical analyses of mutant RET proteins, we previously predicted the potentiality that amino-acid substitution for cysteine 611 as well as cysteines 609, 618, and 620 would promote the development of MEN 2A/FMTC and HSCR. This clinical case substantiates our suggestion for the mechanism of the development of both the diseases. 相似文献
18.
Regulation of proliferation and apoptosis in sporadic and hereditary medullary thyroid carcinomas and their putative precursor lesions 总被引:3,自引:0,他引:3
Hinze R Gimm O Taubert H Bauer G Dralle H Holzhausen HJ Rath FW 《Virchows Archiv : an international journal of pathology》2000,437(3):256-263
C-cell hyperplasia (CCH) and medullary thyroid carcinoma (MTC) in patients affected by germline mutations of the RET oncogene
represent an exceptional opportunity to study the regulation of proliferation and apoptosis during tumour initiation and progression.
In 56 specimens [CCH, n=1; MTC with CCH, n=26; MTC, n=20; lymph-node metastasis (LNM), n=9] from 46 patients [multiple endocrine neoplasia type 2a (MEN2a), n=24; MEN2b, n=2; familiar MTC (FMTC), n=4; sporadic MTC, n=16] and 3 cases of non-neoplastic CCH, proliferation activity (MIB1), the rate of apoptosis [dUTP nick end labelling (TUNEL)]
and expression of p53, bcl-2, bcl-x and bax were investigated and compared with clinical data. In MEN-associated CCH and small
MTC, bcl-2 was strongly expressed, bcl-x was moderately expressed and bax was only weakly expressed. Advanced tumours and
LNM did show a more heterogeneous bcl-2 staining accompanied by an increased bax expression and accelerated proliferation.
The rate of apoptosis was extremely low in all investigated tumours. P53 was detectable in three patients with rapidly growing
and extensively metastasising MTC. No somatic p53 mutations were found. Hereditary MTC with germline RET mutations at codon
918 (MEN2b) and codon 634 revealed a bias towards a higher proliferation activity at a younger age and are more frequently
accompanied by LNM. CCH and MTC are characterised with a preponderance of bcl-2 as a factor blocking the programmed cell death.
While MTC, in general, is a slowly growing tumour, a minority of tumours do progress rapidly with high proliferation. The
factors leading to an accelerated tumour progression do not seem to take their effect via the regulation of apoptosis. Certain
alterations of RET are supposed to have a direct or indirect implication on proliferation and, because of this, an effect
on the clinical course.
Received: 10 January 2000 / Accepted: 1 March 2000 相似文献
19.
Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. 总被引:4,自引:3,他引:1 下载免费PDF全文
P. Komminoth E. Kunz O. Hiort S. Schrder X. Matias-Guiu G. Christiansen J. Roth P. U. Heitz 《The American journal of pathology》1994,145(4):922-929
The suitability of formalin-fixed and paraffin-embedded tumor material was evaluated for molecular analysis of the RET proto-oncogene. We analyzed exons 10, 11, and 16 for point mutations in seven sporadic and six multiple endocrine neoplasia (MEN) 2A-associated pheochromocytomas by a nonradioactive single-strand conformation polymorphism assay followed by nonradioactive direct sequencing of PCR-amplified DNA using an automated DNA sequencer. All MEN 2A-associated pheochromocytomas contained a heterozygous missense germline mutation within cystine codons of the cysteine-rich extracellular domain encoded by exons 10 and 11. Mutations were located in codon 619 (TGC-->TCC; Cys-->Ser) in one, in codon 635 (TGC-->CGC; Cys--Arg) in three, and in codon 635 (TGC-->TAC; Cys-->Tyr) in two pheochromocytomas. No tumor-specific (somatic) mutations were detected in exons 10, 11, and 16 of the sporadic pheochromocytomas. These data support recent findings that germline point mutations that are clustered in distinct cysteine codons of the RET proto-oncogene are involved in the neoplastic phenotype of the MEN 2A syndrome. Our results demonstrate that both nonradioactive single-strand conformation polymorphism and direct sequencing are suitable methods to detect single base substitutions in DNA extracted from archival material. 相似文献
20.
Activating germline mutations in the cysteine-rich domain of the RET
proto-oncogene are found in >92% of the cases of multiple endocrine
neoplasia type 2A (MEN2A) and 85% of familial medullary thyroid carcinoma
(FMTC). In virtually 100% of patients with identified mutations one of five
cysteines is altered by a missense mutation. In a MEN2A family with 14
affected and 11 unaffected living members, hypercalcemia was diagnosed in
eight patients and histological evaluation revealed parathyroid hyperplasia
in all cases examined (10/10). No member of this family showed any evidence
for the existence of pheochromocytoma. This is the first documentation of a
family without pheochromocytoma but with a high incidence of parathyroid
disease. Genetic analysis revealed the presence of an unusual heterozygous
mutation in exon 11 of the RET proto-oncogene representing a duplication of
12 bp resulting in the insertion of four amino acids between codon 634
(Cys) and 635 (Arg), thus creating an additional cysteine residue.
相似文献